Hong Seng Consolidated Berhad

KLSE:HONGSENG Stock Report

Market Cap: RM 76.6m

Hong Seng Consolidated Berhad Valuation

Is HONGSENG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HONGSENG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HONGSENG (MYR0.02) is trading below our estimate of fair value (MYR0.2)

Significantly Below Fair Value: HONGSENG is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for HONGSENG?

Key metric: As HONGSENG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HONGSENG. This is calculated by dividing HONGSENG's market cap by their current revenue.
What is HONGSENG's PS Ratio?
PS Ratio5.1x
SalesRM 14.95m
Market CapRM 76.64m

Price to Sales Ratio vs Peers

How does HONGSENG's PS Ratio compare to its peers?

The above table shows the PS ratio for HONGSENG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.7x
DCHCARE DC Healthcare Holdings Berhad
2.8xn/aRM 159.4m
SMILE Smile-Link Healthcare Global Berhad
1xn/aRM 32.8m
METRO Metro Healthcare Berhad
4x12.3%RM 193.2m
OPTIMAX Optimax Holdings Berhad
2.9x11.3%RM 350.4m
HONGSENG Hong Seng Consolidated Berhad
5.1xn/aRM 76.6m

Price-To-Sales vs Peers: HONGSENG is expensive based on its Price-To-Sales Ratio (5.1x) compared to the peer average (2.7x).


Price to Sales Ratio vs Industry

How does HONGSENG's PS Ratio compare vs other companies in the Asian Healthcare Industry?

62 CompaniesPrice / SalesEstimated GrowthMarket Cap
HONGSENG 5.1xIndustry Avg. 1.6xNo. of Companies64PS01.63.24.86.48+
62 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: HONGSENG is expensive based on its Price-To-Sales Ratio (5.1x) compared to the Asian Healthcare industry average (1.6x).


Price to Sales Ratio vs Fair Ratio

What is HONGSENG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HONGSENG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate HONGSENG's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies